Next Article in Journal
Transhepatic Vascular Access for Implantation of a Watchman Left Atrial Appendage Closure Device
Previous Article in Journal
Successful Amplified-Natural-Killer Cell (ANK) Therapy Administered to a Patient with Smoldering Adult T-Cell Leukemia in Acute Crisis
Article Menu

Export Article

Open AccessCase Report
Reports 2018, 1(2), 14; https://doi.org/10.3390/reports1020014

Rett Syndrome: Treatment with IGF-I, Melatonin, Blackcurrant Extracts, and Rehabilitation

1
Scientific Direction, Medical Center Foltra, 15886 Teo, Spain
2
Speech Therapy, Medical Center Foltra, 15886 Teo, Spain
3
Psychomotricity, Medical Center Foltra, 15886 Teo, Spain
4
EINA, Medical Center Foltra, 15886 Teo, Spain
5
Physiotherapy, Medical Center Foltra, 15886 Teo, Spain
*
Author to whom correspondence should be addressed.
Received: 6 August 2018 / Revised: 30 August 2018 / Accepted: 2 September 2018 / Published: 4 September 2018
Full-Text   |   PDF [23355 KB, uploaded 4 September 2018]   |  

Abstract

(1) This study describes the good evolution of a 6-year-old girl genetically diagnosed (R106X) with Rett syndrome (RTT), after having been treated with IGF-I, melatonin (MT), blackcurrant extracts (BC) and rehabilitated for 6 months. (2) The patient stopped normal development in the first year of age. The patient showed short stature and weight and fulfilled the main criteria for typical RTT. Despite her young age, there was pubic hair (Tanner II), very high plasma testosterone, and low levels of plasma gonadotrophins. There were no adrenal enzymatic deficits, and abdominal ultrasound studies were normal. The treatment consisted of IGF-I (0.04 mg/kg/day, 5 days/week, subcutaneous (sc)) for 3 months and then 15 days of rest, MT (50 mg/day, orally, without interruption) and neurorehabilitation. A new blood test, after 3 months of treatment, was absolutely normal and the pubic hair disappeared (Tanner I). Then, a new treatment was started with IGF-I, MT, and BC for another 3 months. In this period, the degree of pubertal development increased to Tanner III (pubic level), without a known cause. (3) The treatment followed led to clear improvements in most of the initial abnormalities, perhaps due to the neurotrophic effect of IGF-I, the antioxidant effects of MT and BC, and the cerebral increase in the cyclic glycine-proline (cGP) achieved with administration of BC. (4) A continuous treatment with IGF-I, MT, and BC appears to be useful in RTT. View Full-Text
Keywords: MeCP2; IGF-I; melatonin; blackcurrant extracts; cyclic glycine-proline; oxidative stress; Speech Therapy; Neurostimulation; physiotherapy; EINA MeCP2; IGF-I; melatonin; blackcurrant extracts; cyclic glycine-proline; oxidative stress; Speech Therapy; Neurostimulation; physiotherapy; EINA
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Devesa, J.; Devesa, O.; Carrillo, M.; Casteleiro, N.; Devesa, A.; Llorente, D.; González, C. Rett Syndrome: Treatment with IGF-I, Melatonin, Blackcurrant Extracts, and Rehabilitation. Reports 2018, 1, 14.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Reports EISSN 2571-841X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top